My Pediatric Doctor Just Added AI-Powered Blood Health Screening for Families Nationwide

For parents, one of the most frustrating parts of managing a child's health is what happens between doctor visits. Symptoms come and go. Concerns arise at 10 p.m. on a Tuesday. And conditions like anemia, one of the most common issues in pediatric care, often go undetected until a lab visit happens to catch them.

A new collaboration announced on September 22, 2026, is taking steps to help change that.

QC Healthcare, the parent company behind My Pediatric Doctor, has announced a strategic partnership with Sanguina, an AI-powered digital health company that has developed a non-invasive way to screen for blood health conditions using nothing more than a smartphone camera and a patient's fingernails. The technology will be integrated directly into the My Pediatric Doctor platform, giving families a new tool to monitor key blood health indicators from home, between visits, and without a needle.

The way it works is straightforward. A patient records a brief video of their fingernails using their smartphone. Sanguina's artificial intelligence then analyzes that footage to screen for signs of anemia by estimating hemoglobin levels, and to evaluate circulation by measuring how quickly blood returns to the fingertips after light pressure is applied. Both of these assessments have traditionally required either a lab draw or an in-person clinical evaluation. This technology makes them accessible on demand, at home, in minutes.

For pediatric patients specifically, this development addresses a gap that parents know well. Anemia affects a significant number of children and is closely tied to nutrition, growth, and chronic disease management. It is also one of the conditions most likely to go unnoticed between scheduled well visits, particularly in families where getting to a separate lab appointment is a logistical challenge. With this collaboration, a My Pediatric Doctor visit can now be supported by real blood health data gathered at home, giving clinicians more context and giving families more peace of mind.

Anemia affects an estimated 1.9 billion people globally, with children among the most vulnerable populations. The ability to screen for it conveniently and non-invasively is a step toward catching it earlier, managing it more proactively, and connecting families with appropriate follow-up care before the condition becomes more serious.

"By combining QC Healthcare's nationwide virtual care ecosystem with Sanguina's innovative AI technology, we can help bring meaningful blood-health information into the home and connect it to licensed clinical care," said Eric Doherty, CEO of QC Healthcare. "That opportunity extends across the families served by My Pediatric Doctor today."

For parents using My Pediatric Doctor, this is what the next generation of telehealth can look like: not just convenient access to a doctor, but smarter, more connected care that supports your family between visits as well as during them.

References / Sources

1. QC Healthcare. QC Healthcare Announces Strategic Collaboration with Sanguina to Deploy AI-Powered Blood Health Technologies Across Nationwide Healthcare Platforms. Press Release, September 22, 2026. PRNewswire.com.